Cite
HARVARD Citation
Hoogstrate, Y. et al. (2020). EGFR mutations are associated with response to depatux-m in combination with temozolomide and result in a receptor that is hypersensitive to ligand. Neuro-oncology advances. 2 (1), p. . [Online].